These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 24060096

  • 1. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN, van Asselt AD, Tomini F, Armstrong N, Allen A, Noake C, Khan K, Severens JL, Kleijnen J, Westwood ME.
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [Abstract] [Full Text] [Related]

  • 2. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J, Mújica-Mota R, Coelho H, Ocean N, Barnish M, Packman D, Dodman S, Cooper C, Snowsill T, Kay T, Liversedge N, Parr M, Knight L, Hyde C, Shennan A, Hoyle M.
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [Abstract] [Full Text] [Related]

  • 3. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V, Saccone G.
    Cochrane Database Syst Rev; 2019 Jul 29; 7(7):CD006843. PubMed ID: 31356681
    [Abstract] [Full Text] [Related]

  • 4. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
    Stock SJ, Horne M, Bruijn M, White H, Heggie R, Wotherspoon L, Boyd K, Aucott L, Morris RK, Dorling J, Jackson L, Chandiramani M, David A, Khalil A, Shennan A, Baaren GV, Hodgetts-Morton V, Lavender T, Schuit E, Harper-Clarke S, Mol B, Riley RD, Norman J, Norrie J.
    Health Technol Assess; 2021 Sep 29; 25(52):1-168. PubMed ID: 34498576
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY, Lee JY, Kim HM, Kim MJ, Cha HH, Seong WJ.
    BMC Pregnancy Childbirth; 2019 Jul 11; 19(1):241. PubMed ID: 31296172
    [Abstract] [Full Text] [Related]

  • 6. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling.
    Honest H, Forbes CA, Durée KH, Norman G, Duffy SB, Tsourapas A, Roberts TE, Barton PM, Jowett SM, Hyde CJ, Khan KS.
    Health Technol Assess; 2009 Sep 11; 13(43):1-627. PubMed ID: 19796569
    [Abstract] [Full Text] [Related]

  • 7. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC, Khalil A, Wing D, Schleussner E, Surbek D.
    Ultrasound Obstet Gynecol; 2018 Oct 11; 52(4):442-451. PubMed ID: 29920825
    [Abstract] [Full Text] [Related]

  • 8. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC, Navas H, Marcos M, Iza A, De Diego M, Rando D, Melchor I, Burgos J.
    Ultrasound Obstet Gynecol; 2018 May 11; 51(5):644-649. PubMed ID: 28850753
    [Abstract] [Full Text] [Related]

  • 9. The future of Cochrane Neonatal.
    Soll RF, Ovelman C, McGuire W.
    Early Hum Dev; 2020 Nov 11; 150():105191. PubMed ID: 33036834
    [Abstract] [Full Text] [Related]

  • 10. Accuracy of fetal fibronectin for assessing preterm birth risk in asymptomatic pregnant women: a systematic review and meta-analysis.
    Dos Santos F, Daru J, Rogozińska E, Cooper NAM.
    Acta Obstet Gynecol Scand; 2018 Jun 11; 97(6):657-667. PubMed ID: 29355887
    [Abstract] [Full Text] [Related]

  • 11. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY, Seto MTY, Lewis H, Cheung KW.
    BMC Pregnancy Childbirth; 2023 Apr 04; 23(1):225. PubMed ID: 37016314
    [Abstract] [Full Text] [Related]

  • 12. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
    Berghella V, Saccone G.
    Am J Obstet Gynecol; 2016 Oct 04; 215(4):431-8. PubMed ID: 27133012
    [Abstract] [Full Text] [Related]

  • 13. Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.
    Smith GC, Moraitis AA, Wastlund D, Thornton JG, Papageorghiou A, Sanders J, Heazell AE, Robson SC, Sovio U, Brocklehurst P, Wilson EC.
    Health Technol Assess; 2021 Feb 04; 25(15):1-190. PubMed ID: 33656977
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein-1 Testing to Predict Preterm Delivery in Symptomatic Women: A 10-Year Retrospective Study.
    Chen MX, Dansereau J, Hoag GN.
    J Obstet Gynaecol Can; 2020 Aug 04; 42(8):971-976. PubMed ID: 32345553
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.
    van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Scheepers HCJ, Spaanderman MEA, Bloemenkamp KWM, Haak MC, Bax CJ, Cornette JMJ, Duvekot JJ, Nij Bijvanck BWA, van Eyck J, Franssen MTM, Sollie KM, Vandenbussche FPHA, Woiski M, Bolte AC, van der Post JAM, Bossuyt PMM, Opmeer BC, Mol BWJ.
    Ultrasound Obstet Gynecol; 2018 May 04; 51(5):596-603. PubMed ID: 28370518
    [Abstract] [Full Text] [Related]

  • 16. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V, Hayes E, Visintine J, Baxter JK.
    Cochrane Database Syst Rev; 2008 Oct 08; 2008(4):CD006843. PubMed ID: 18843732
    [Abstract] [Full Text] [Related]

  • 17. Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta.
    Chuck AW, Thanh NX, Chari RS, Wilson RD, Janes-Kelley S, Wesenberg JC.
    J Obstet Gynaecol Can; 2016 Jul 08; 38(7):659-666.e6. PubMed ID: 27591351
    [Abstract] [Full Text] [Related]

  • 18. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J, Chedraui P, Hidalgo L, Medina M.
    J Matern Fetal Neonatal Med; 2009 Feb 08; 22(2):89-93. PubMed ID: 19085632
    [Abstract] [Full Text] [Related]

  • 19. Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study.
    Stock SJ, Wotherspoon LM, Boyd KA, Morris RK, Dorling J, Jackson L, Chandiramani M, David AL, Khalil A, Shennan A, Hodgetts Morton V, Lavender T, Khan K, Harper-Clarke S, Mol B, Riley RD, Norrie J, Norman J.
    BMJ Open; 2018 Apr 19; 8(4):e020795. PubMed ID: 29674373
    [Abstract] [Full Text] [Related]

  • 20. The fetal fibronectin test is superior to cervical length measurement in predicting preterm birth in twin pregnancies: a retrospective observational study.
    Holzer I, Koch-Trappel M, Leitich H, Meyer EL, Farr A, Helmer H.
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr 19; 247():22-25. PubMed ID: 32058186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.